Jeil Pharmaceutical Group holds regular shareholders’ meeting… “Cash 14% dividend decision”

© News1

Cheil Pharma Holdings and Jeil Pharmaceutical held a regular shareholders’ meeting on the 23rd and decided to pay 14% cash dividends each.

At the shareholders’ meeting that day, the two companies decided on cash dividends and the appointment of outside directors and audit committee members. The cash dividend rate is 14%, which is the same level as last year’s regular shareholders’ meeting.

In addition, Cheil Pharma Holdings appointed Kibong Park, former head of the Yangjaenam Financial Center of KB Kookmin Bank, and Lee Dong-yeol, former head of Lotte Insurance Corporate Sales Division, as outside directors and audit committee members.

“As a holding company, Cheil Pharma Holdings President Han Sang-cheol said, “As a holding company, we want to prepare for the future by laying the foundation for a 100-year company.”

Seong Suk-je, president of Jeil Pharmaceutical said, “The support of the shareholders and the dedication of all executives and employees is the driving force that enabled us to achieve a 3% growth rate compared to the previous year.” Said.

[email protected]